Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003113869 | SCV003796962 | pathogenic | Tatton-Brown-Rahman overgrowth syndrome | 2022-08-31 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the DNMT3A gene has been identified. Loss-of-function variants in DNMT3A are known to be pathogenic (PMID: 24614070). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. Isolated whole-gene deletions of DNMT3A have not been reported in the literature. However, larger copy number events that include this gene have been reported (PMID: 26866722, 29900417). For these reasons, this variant has been classified as Pathogenic. |